Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia.
Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia.
复制标题
DOI：
10.1016/j.leukres.2009.06.006
复制
发表时间：
2010-03
影响因子：
2.7
通讯作者：
M. Kaderi;M. Mansouri;N. Zainuddin;N. Cahill;Rebeqa Gunnarsson;M. Jansson;E. Kimby;A. Åleskog;J. Lundin;B. Glimelius;M. Melbye;G. Juliusson;J. Jurlander;R. Rosenquist
中科院分区：
文献类型：
--
作者：
M. Kaderi;M. Mansouri;N. Zainuddin;N. Cahill;Rebeqa Gunnarsson;M. Jansson;E. Kimby;A. Åleskog;J. Lundin;B. Glimelius;M. Melbye;G. Juliusson;J. Jurlander;R. Rosenquist
